Better Buy: Axsome Therapeutics vs. Johnson & Johnson

Published on August 24, 2022

Axsome Therapeutics (AXSM) and Johnson & Johnson (JNJ) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the pharmaceutical sector. But which of...

Continue reading on website
Other news

Deepfakes for all: Uncensored AI art model prompts ethics questions

August 24, 2022
A new open source AI image generator capable of producing realistic pictures from any text prompt has seen stunningly swift uptake in its first week. Stability AI’s Stable Diffusion, high fidelity but capable of being run on off-the-shelf consumer hardware, is now in use by art generator services like Artbreeder, Pixelz.ai and more. But the model’s unfiltered nature means not all the use has been

Is Cisco Systems a Buy After Mixed Earnings Results?

August 24, 2022
Networking giant Cisco (CSCO) reported mixed fourth-quarter earnings results but provided impressive guidance for fiscal 2023, supported by strong demand for cloud computing infrastructure and telecom networks combined with easing...